Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors [Phase 2]

View source ↗

Summary

Arsenic trioxide was studied in a Phase 2 trial for children with advanced neuroblastoma and other childhood solid tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Extragonadal Germ Cell Tumor
• Germ Cell Tumor
• Liver Cancer
• Neuroblastoma
• Ovarian Cancer
• Retinoblastoma
• Sarcoma

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 2 | Status: COMPLETED | Results posted: 2015-11-25